The chief function of the lung is pulmonary gas exchange which requires adequate levels of ventilation and perfusion of the alveoli. The lung must match pulmonary oxygen uptake (Vo2) and elimination of carbon dioxide (Vco2) to the whole body metabolic oxygen consumption and carbon dioxide production whatever the oxygen and carbon dioxide partial pressures in the arterial blood.
During the first half of this century'2 the heterogeneity of the ventilation-perfusion (VA/Q) ratios within the lung was identified as a factor causing hypoxaemia ( the behaviour of oxygen and carbon dioxide in the blood"8 facilitated substantial contributions to the numerical analysis of pulmonary gas exchange. 9 These studies showed that traditional variables derived from physiological gases (Pao2, Paco2, alveolar-arterial Po2 difference (A-aPo2), venous admixture, and physiological dead space) are sensitive to VA/X mismatch, but they also vary with changes in total lung indices such as minute ventilation, cardiac output, and inspired Po2. This behaviour can lead to misinterpretations in the clinical setting. In the mid 1960s Farhi'°d emonstrated the quantitative relation of the blood-gas partition coefficient (k) of a gas -the VA/Q ratio -and the capacity of an alveolar unit to exchange that gas. Using the principles laid down by the work of Farhi,'°and extending the application of inert gas elimination by adding more gases, the multiple inert gas elimination technique (MIGET)"-13 was developed in the mid 1970s. This technique provides more information concerning the role of the VA/Q relations on pulmonary gas exchange than previously available. It overcomes some important drawbacks of other methods such as the topographical radioactive tracer based techniques (ventilation-perfusion scans) which have limited resolution and thus underestimate the degree of VA/Q inequality. Approaches'4 similar to MIGET but using different inspired oxygen fractions (Fio2) rather than different inert gases as the forcing function erroneously assumed no effect of Fio2 on VA/Q inequality. The MIGET, in addition to its ability to estimate VA/Q distributions in real lungs, provides information on other pulmonary factors VAXQ=ventilation-perfusion; Hb=haemoglobin; P50 =Po2 that corresponds to 50% oxyhaemoglobin saturation.
causing hypoxaemia (table) and also allows a numerical analysis of the influence of extrapulmonary factors on arterial P02, as described below. During the past 15 years a great deal of work has been done on the theoretical basis of the MIGET (to define its limits), different modalities of the technique have been developed, and a substantial amount of clinical research has been produced by several groups around the world. This introductory article to the series on the contribution of MIGET to pulmonary medicine aims to report the essentials of the technique, namely: (1) principles of measurement, (2) information content, (3) limitations, and (4) some practical details of the different modalities of the method. The mathematical complexities of the technique will be omitted as they are available elsewhere to the interested reader.'"-"3
Finally, we will analyse the contribution of the MIGET to the understanding of the physiology of the normal lung and its behaviour in stress situations such as exercise and altitude.
Physiological basis and assumptions
The MIGET constitutes a conceptual and technical development of the historical work carried out by Kety,'5 Farhi,'0 and others '6 analysing the relations between inert gas exchange in the lungs, the VA/4 ratio distribution, and the solubilities of the gases used. These authors established the following basic equation for a single lung unit. This equation expresses mass balance during steady state elimination of the gas such as that which occurs during intravenous infusion of a dissolved gas in solution:
PC'PA = PV X/(X + VA/() covering a broad spectrum of partition coefficients from 0005 (SF6) to 300 (acetone) to characterise the distribution of the VA/Q ratios within the whole lung. Equation 3, describing the events in a single lung unit, can be applied to each lung unit and the results summed to represent total lung gas exchange:
Here, (j and VAJ represent, respectively, the fractional perfusion and ventilation of each of the N lung units present in the lung n=j n=j (E i = E VAJ = 1). For each inert gas the n=l n=l retentions are calculated as the ratio between arterial partial pressure and mixed venous partial pressure (R = Pa/Pv) and the excretions as the ratio between mixed expired partial pressure and mixed venous partial pressure (E = PE/ Piv). By using a multicompartmental approach with enforced smoothing, the retentions of the six inert gases allow the estimation of a continuous distribution of the pulmonary blood flow against VA/( ratios on a logarithmic scale ( fig  2) . Similarly, the excretions of the six inert (equation 1) This indicates that both end capillary (Pc') and alveolar (PA) partial pressures of an inert gas (assumed to be equal in a single lung unit'7) depend on the partial pressure of this gas in the venous side of the capillary (Pv) and the expression in the right hand side of the equation, which includes the solubility of the gas (k), expressed as the partition coefficient, and the VA/4 ratio of the lung unit. Equation 1 can be rearranged as follows:
The Pc'/Pv ratio indicates the r of the gas in the blood while the express its excretion (E) to the Thus, equation 2 can be expresse lowing way: 
CHARACTERISTICS OF THE INERT GASES
The gases must show a linear relation between partial pressure and concentration in blood (they must obey Henry's law). It is also assumed that diffusion equilibration occurs between alveolar gas and end capillary blood for each inert gas.
THE LUNG MODEL
The lung is considered to consist of a number of homogeneous compartments arranged in parallel, each with constant and continuous ventilation and perfusion. The mathematical model assumes that the distribution of ventilation and perfusion have regular contours and do not present sudden irregularities. Further important assumptions are smoothing (described earlier) and non-negativity of perfusion. A substantial amount of research has been done to test the principal assumptions and constraints of the MIGET.'3 1-22 All are acceptable provided that the technique is used properly, but must be kept in mind when results are interpreted.
Information content and limitations
The principal objective in using the MIGET is to estimate the distribution of ventilation-perfusion ratios. However, a number of additional pieces of information become available from inert gas data, and all are now summarised. This graphical representation is useful in giving a general overview of the distribution. It identifies domains of interest along the VA/Q axis (below normal, normal, and above normal VA/Q ratio), and suggests patterns of distribution as unimodal, bimodal, or trimodal (from six gases it is mathematically impossible to resolve more than three modes).
The graphical representation does not in itself quantify the degree of inequality. To do this we, and others, have developed a series of convenient parameters of the distributions of both ventilation and blood flow. One is the first moment of the distribution (on a log scale) which is simply the mean abscissa value, or mean VA/Q ratio, of each curve. More informative are the second moments of the distributions about their respective means on a log scale, and the square roots of these moments have been called log SDQ and log SDv for blood flow (() and ventilation (V) curves respectively. The letters "SD" refer to standard deviation, which is applicable only if the entire distribution is logarithmically normal. In other cases (skewed or multimodal curves) there is nothing wrong with the parameter, but it is no longer strictly reflective of the standard deviation. These parameters then quantify the amount of VA/( inhomogeneity. This semantic issue should not limit applicability of the parameter which is broad and well suited to comparing distributions -for example, before and after interventions. Useful additional parameters are the fractions of total ventilation and blood flow within arbitrarily defined ranges of VA/'Q ratio.
Since the distribution in normal young subjects is completely contained within the two decade range between VA/Q=0-1 and VA/Q= 100, a conservative parameter of low VA/0 abnormalities is the total (fractional) blood flow in units whose VA/Q ratio is < 0- In a corresponding manner the dead space value returned by the computer algorithm reflects anatomical (conducting airway) dead space, together with any external instrumental dead space and also that part of alveolar ventilation that reaches alveoli which are, for any reason, completely unperfused (or which have a VA/( ratio of > 100).
It is not possible from MIGET data alone to further subdivide either shunt or dead space into its potential components.
DIFFUSION LIMITATION OF GAS EXCHANGE
The VA/( distribution, shunt, and dead space are parameters based on convective gas and blood flow through the lung, and the MIGET algorithm is based on a theory that expressly assumes that all diffusive processes affecting pulmonary gas movement are sufficiently rapid not to affect gas exchange. That the MIGET algorithm can so often adequately fit experimental data in the face of these assumptions suggests that under most conditions the assumptions are reasonable. Two forms of diffusion limitation are recognised as being theoretically possible, however; (1) that associated with diffusion of gases between alveolar gas and capillary blood, and (2) that associated with diffusive mixing of inspired gas with resident alveolar gas.
The former problem, when it occurs, impairs oxygen exchange much earlier than inert gas exchange; the inert gases are in fact essentially invulnerable to this form of diffusion limitation.2527 Consequently, under such conditions, application of MIGET will still estimate the VA/Q distribution despite oxygen diffusion limitation; however, oxygen exchange will be affected not only by VA/( inequality but also by diffusion limitation. When the MIGET algorithm uses the derived VA/Q distribution to estimate the amount of hypoxaemia that VA/() inequality should produce,25 27 the value of the expected arterial Po2 will be too high (when compared with the measured arterial Po2) because of the depression of actual arterial Po2 by diffusion limitation. Thus, if the expected arterial Po2 exceeds the measured value by more than experimental error, the presence of oxygen diffusion limitation is inferred. If one assumes a uniform distribution of lung oxygen diffusing capacity to blood flow, it is then possible to compute the oxygen diffusing capacity that would reconcile the measured and expected arterial Po2 values.28 This is a useful tool when characterising impaired oxygen diffusive equilibration in the lung. Two other phenomena may also cause a similar difference between expected and actual arterial Po2values. Firstly, significant pulmonary tissue oxygen utilisation which is hypothesised to occur, for example, in pneumonia would result in a lower arterial Po2 than the non-metabolised inert gases would predict. This has, however, not been found. 29 Secondly, post-pulmonary shunts via the bronchial and/or thebesian circulations may depress actual arterial Po2 but not affect inert gas exchange, thus also resulting in a higher expected Pao2. It can be difficult to exclude this phenomenon when expected Pao2 exceeds the measured value, but the good agreement between expected and measured values almost always seen at rest suggests that such shunts are generally undetectable. During normoxic heavy exercise expected Pao2 often exceeds the measured value, suggesting diffusion limitation for oxygen, but the relative importance of diffusion limitation and postpulmonary shunt are not definitively ascertainable. However, logic favours diffusion limitation for two reasons: (1) the expected to measured difference becomes greater in hypoxia, and (2) the calculated post-pulmonary shunt would (especially in hypoxia) have to exceed 10% of the cardiac output, an unreasonable value.
Impaired gas phase diffusive mixing can also be identified by MIGET. Here the factor that separates vulnerability of different gases to this phenomenon is the gas molecular weight. Hence oxygen (MW = 32) is relatively invulnerable to this problem compared with the gases SF6 (MW = 146) and enflurane (MW = 180) used in the MIGET. The other gases used in MIGET have molecular weights ranging from 30 (ethane) to 74 (ether). Consequently, if molecular weight is an important determinant of inert gas exchange it would affect each of the six gases differently and thus prevent the MIGET algorithm from fitting the measured inert gas data accurately. This is because the algorithm accounts for the solubility of each gas but ignores molecular weight. One would therefore expect a poor fit to the data by the algorithm and, in particular, directional errors in fitting the data that reflected the molecular weight for each gas. Thus high molecular weight gases would be retained in the blood to a greater degree, and low molecular weight gases to a lesser degree, than would be expected from solubility alone. In normal animals and subjects such evidence for gas phase diffusive limitation is difficult to obtain, but many years ago Truog et reflect the different gas exchange process of avian versus mammalian lungs -that is, by modelling cross-current rather than alveolar gas exchange" -the RS S reverted to normal for the same data.
MEASUREMENT OF CARDIAC OUTPUT Steady state mass balance equations are the basis of the MIGET. Thus, since the inert gases are infused intravenously rather than inhaled they are absent from inspired gas, much like carbon dioxide. Consequently inert gas output measured by expired gas analysis (total ventilation times gas concentration) equals that computed as the product of the difference between the pulmonary arterial and systemic arterial inert gas concentrations and cardiac output.
In the presence of pulmonary and systemic arterial catheters it is thus a straightforward (2) total ventilation, (3) cardiac output, and (4) Vo2 (metabolic rate).
As described above in the section on diffusion limitation, it is possible to predict the arterial Po2 expected from the measured VA/( inequality and the particular combination of extrapulmonary factors that existed at the time of measurement. The MIGET algorithm, however, allows the observer to change any or all of the extrapulmonary factors, and then to recompute the expected value of arterial Po2. In addition to the four primary extrapulmonary variables (table) secondary variables such as haemoglobin concentration, haemoglobin P50, body temperature, and blood acid-base status can also be changed singly or in any combination.
Such flexibility is useful in understanding not only expected effects of therapeutic interventions, but also in separately determining the quantitative role of each extrapulmonary factor when they change between two conditions of MIGET measurement. For example, if a vasodilator was given to a patient with high pulmonary artery pressure cardiac output may well increase, while at the same time the VA/Q distribution may change for the worse. Arterial P02 will reflect the integrated effect of these changes. It is a simple matter to execute the MIGET algorithm (a) with the data obtained before giving the drug, (b) using the post-drug inert gas data with the predrug cardiac output, and (c) using all post-drug data to study the individual influences on arterial Po2 of each factor. It is similarly possible to use the algorithm to separately assess, for example, the effect of shunt versus that of VA/Q inequality on arterial Po2. Finally, a third modality of the MIGET34 requiring only mixed expiratory and peripheral venous sampling is also available. This is obtained from a distally oriented 20-gauge cannula inserted into a peripheral vein (usually in the forearm opposite to the side of the infusion of the inert gas solution). Because inert gases are not metabolised in the tissues of the hand, and after some 90 minutes of inert gas infusion in a resting position, virtual equilibration between blood and tissues is achieved and the peripheral venous blood reflects the inert gas concentrations of the inflowing arterial blood. In this condition partial pressures of the inert gases in the peripheral vein (Pven) have been shown to be 95% of Pa (Pa=.Pven/0 95) and reproducible enough to permit substitution of peripheral venous for arterial sampling. However, since (T is not directly measured there is still an unknown in equation 7 . Cardiac output can be estimated within a reasonable range on the basis of relatively simple non-invasive procedures such as Doppler echocardiography. By numerical analysis it has been shown that the log SDQ and log SDv are mostly insensitive to the uncertainty of the estimation of cardiac output. It must be pointed out, however, that this approach without arterial sampling is not useful for estimating the first moment of the distributions, the amount of shunt and dead space, nor the percentage of perfusion or ventilation at a given range of VA/Q ratios. By contrast, this less invasive approach of the MIGET is particularly useful in those situations wherein the main focus of interest is the shape and the dispersion of the VA/(. distributions, and arterial catheterisation needs to be avoided because repeated measurements over time are planned. The results of this modality have been validated by two different studies in patients with asthma using repeated measurements almost daily or weekly.3536 EXPERIMENTAL DETAILS AND DATA PROCESSING The ability to obtain accurate information using the MIGET requires careful and detailed technical aspects. The different steps of the data collection described below must be followed carefully to maintain the experimental error within the tolerable limits and to preserve the steady state.
Preparation of the inert gas solution for sterile infusion A mixture of the six inert gases is equilibrated with 1 litre of either normal saline or 5% dextrose. A tank of gas containing approximately 20% SF6, 20% cyclopropane, and 60% ethane is connected to the plastic bag with the solvent by using sterile intravenous tubing with a 0-22 gm Millipore filter inserted. Gas from the tank is then pumped into the bag until the latter is somewhat distended. The bag is vigorously shaken for approximately one minute and the gas in the bag is then vented to the atmosphere. This cycle should be repeated once to reach full equilibration between the saline or dextrose and the tank gas mixture. Next, 0 7 ml liquid diethyl ether/l saline is transferred into the bag, followed by the addition of 7 ml liquid acetone/l, and finally, 3 ml liquid enflurane/l. The bag is then gently inverted several times to facilitate the distribution of the last three gases into the liquid phase. Each of these steps must be done using sterile disposable material and following the necessary precautions to preserve sterility.
Infusion of the inert gas solution
The solution is infused into a peripheral superficial vein of the forearm by means of a roller pump directly from the bag in which it was prepared. A fresh 0-22 jim Millipore filter is inserted into the line to preserve sterility. A constant and smooth rate of infusion of 3 ml/ min is used in subjects studied at rest. To achieve a steady state a period of about 30 minutes with the infusion running is usually required before any sampling is carried out.
Sampling procedure After ensuring quiet breathing and stable minute ventilation of the subject (often tidal volume, respiratory rate, end tidal Fo2 and Fco2, ECG, and Vo2 are all monitored on line) arterial (4-8 ml) and mixed venous (4-8 ml) samples are drawn simultaneously using heparinised barrel matched ungreased glass syringes. The entire sample is collected by slow steady withdrawal over several respiratory cycles lasting about 30 seconds. For the collection of (duplicate) 15 ml samples of mixed expired gas we use matched barrel/plunger glass syringes. A one way low resistance valve is connected through a large bore heated plastic tube to a mixing box containing a long coiled copper tube 10 cm in diameter and 70 cm in length, which is kept heated several degrees above body temperature. This allows adequate mixing of the expiratory gases without significant loss of soluble inert gases in condensate and produces a lag time that must be allowed for in the sampling procedure. It is advantageous to take duplicate sets of samples in each experimental condition. It is also important to take duplicate control samples of the mixed expired gas and pulmonary and systemic arterial blood before the infusion of the inert gases to exclude spurious signals that could confound the analysis of later samples. The control blood samples are later reused for (duplicate) measurement of the solubilities of the inert gases.
Measurements of inert gas concentrations Before the study the syringes to be used for blood sampling must be weighed both before and after heparinisation. The heparin used should be tested in order to avoid those brands that contain acetone.'7 The mixed expired samples can be directly injected into the gas chromatograph to measure inert gas concentrations. For the blood samples we proceed in the following way. Each syringe is weighed a third time, after blood sampling, in order to measure the volume of blood (calculated as weight divided by density). Density is measured later from pooled samples. Approximately 10 ml of nitrogen is transferred into each syringe for equilibration of inert gases between blood and the nitrogen phase. This procedure is carried out in a shaking water bath at body temperature for approximately 40 minutes. The combined volume of the nitrogen and blood is then measured at body temperature and the gas above the blood is anaerobically transferred to a dry syringe to be measured in the gas chromatograph. The peak of the least soluble gas, SF6, is measured by an electron capture detector (ECD) while the remaining five gases (all hydrocarbons) are measured by a flame ionisation detector (FID). The characteristics of the set-up of the gas chromatograph for the MIGET and the quality control procedures have been detailed elsewhere." 38 The chromatographic peaks so measured from the gas phase after the equilibration procedure are not equal to Pa and Pv of each inert gas. These partial pressures must therefore be calculated using standard mass balance formulae" that take into account (1) between two conditions of MIGET measurement. This information will be extensively reviewed in the forthcoming articles of this series. Next, the different modalities of the MIGET, practical considerations involved in the measurements and the guidelines for quality control have been indicated. Finally, a section has been devoted to the analysis of available data in healthy subjects under different conditions. The lack of systematic information on the VA/4 distributions of older healthy subjects is emphasised, since it will be required to fully understand the changes brought about by diseases that affect the older population.
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